Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Newamsterdam Pharma Company ORDINARY SHARES | 10,473,913 | 10,719,110 | +245,197 | $173.87M | $275.48M | 32.41% | +$101.61M |
| Nuvalent Inc | 2,697,267 | 1,447,267 | -1,250,000 | $275.93M | $113.29M | 13.33% | -$162.64M |
| Pharvaris N V COM | 3,303,381 | 3,303,381 | 0 | $61.18M | $63.33M | 7.45% | +$2.15M |
| Disc Medicine, Inc.(IRON) | 1,795,735 | 983,500 | -812,235 | $88.24M | $62.35M | 7.33% | -$25.89M |
| Dianthus Therapeutics, Inc.(DNTH) | 3,013,423 | 2,689,707 | -323,716 | $82.51M | $58.64M | 6.90% | -$23.87M |
| Savara Inc.(SVRA) | 14,565,457 | 14,565,457 | 0 | $61.76M | $44.72M | 5.26% | -$17.04M |
| Olema Pharmaceuticals, Inc.(OLMA) | 0 | 7,470,214 | +7,470,214 | $0 | $43.55M | 5.12% | +$43.55M |
| Upstream Bio, Inc.(UPB) | 0 | 2,295,322 | +2,295,322 | $0 | $37.74M | 4.44% | +$37.74M |
| Annexon, Inc.(ANNX) | 8,449,748 | 5,249,069 | -3,200,679 | $50.02M | $26.93M | 3.17% | -$23.09M |
| Cidara Therapeutics Inc | 703,080 | 703,080 | 0 | $7.56M | $18.90M | 2.22% | +$11.34M |
| Solid Biosciences Inc | 4,034,582 | 4,034,582 | 0 | $28.12M | $16.14M | 1.90% | -$11.98M |
| Kyverna Therapeutics, Inc.(KYTX) | 3,368,370 | 3,368,370 | 0 | $16.47M | $12.60M | 1.48% | -$3.87M |
| X4 Pharmaceuticals, Inc.(XFOR) | 16,915,784 | 16,915,784 | 0 | $11.32M | $12.41M | 1.46% | +$1.09M |
| Mersana Therapeutics Inc | 8,663,673 | 8,663,673 | 0 | $16.37M | $12.39M | 1.46% | -$3.99M |
| Tango Therapeutics, Inc.(TNGX) | 2,712,008 | 2,712,008 | 0 | $20.88M | $8.38M | 0.99% | -$12.50M |
| Atea Pharmaceuticals, Inc.(AVIR) | 2,485,638 | 2,485,638 | 0 | $8.33M | $8.33M | 0.98% | $0 |
| Rapid Micro Biosystems, Inc.CL A(RPID) | 8,434,560 | 8,434,560 | 0 | $7.51M | $7.59M | 0.89% | +$84.3K |
| Cabaletta Bio, Inc.(CABA) | 2,760,888 | 2,760,888 | 0 | $13.03M | $6.27M | 0.74% | -$6.76M |
| Century Therapeutics, Inc.(IPSC) | 5,410,361 | 5,410,361 | 0 | $9.25M | $5.46M | 0.64% | -$3.79M |
| Xilio Therapeutics, Inc.(XLO) | 4,566,817 | 4,566,817 | 0 | $3.60M | $4.36M | 0.51% | +$764.0K |
| C4 Therapeutics, Inc.(CCCC) | 1,111,910 | 1,111,910 | 0 | $6.34M | $4.00M | 0.47% | -$2.34M |
| Nautilus Biotechnology, Inc.(NAUT) | 2,000,000 | 1,759,000 | -241,000 | $5.70M | $2.96M | 0.35% | -$2.74M |
| Marinus Pharmaceuticals Inc | 2,693,380 | 2,693,380 | 0 | $4.74M | $1.44M | 0.17% | -$3.30M |
| Newamsterdam Pharma CompanyW EXP 99 99 999 *W EXP 99/99/999 | 100,000 | 100,000 | 0 | $700.0K | $1.43M | 0.17% | +$725.0K |
| Invivyd, Inc.(IVVD) | 1,799,595 | 1,799,595 | 0 | $1.84M | $797.4K | 0.09% | -$1.04M |
| Syros Pharmaceuticals Inc | 2,750,151 | 2,750,151 | 0 | $5.91M | $632.0K | 0.07% | -$5.28M |